Therefore, the binding between furin with pro-MT1-MMP or pro-VEGF-C or other tumor-associated enzyme precursors can be regulated by c-Src activity, thereby reducing or changing the expression of these enzymes in order to inhibit the development of gastric cancer invasion and metastasis. This evidence concerns the gene SRC and neoplasm.